Literature DB >> 22580443

The relation between keratoconus and plasma levels of MMP-2, zinc, and SOD.

Hüseyin Ortak1, Erkan Söğüt, Ufuk Taş, Cem Mesci, Durali Mendil.   

Abstract

PURPOSE: To evaluate the levels of matrix metalloproteinase-2 (MMP-2), superoxide dismutase (SOD), and zinc in plasma taken from patients with keratoconus and to investigate the likely association between these factors and keratoconus.
METHODS: A total of 36 patients with keratoconus and 40 control subjects at the Department of Ophthalmology, Faculty of Medicine, Gaziosmanpaşa University, were included in the study. Plasma levels of zinc were determined with atomic absorption spectrometry for all the subjects. Measurements of plasma MMP-2 levels were performed by the enzyme-linked immunosorbent assay method. Total plasma (Cu/Zn and Mn) SOD activity was also determined photometrically.
RESULTS: The plasma concentrations of zinc and MMP-2 were significantly lower in patients with keratoconus than in the healthy controls (P < 0.001). Total plasma SOD levels were significantly higher in patients with keratoconus than in the healthy controls (P < 0.001).
CONCLUSIONS: We detected reduced plasma levels of zinc and MMP-2, and enhanced plasma levels of SOD in patients with keratoconus compared with the healthy subjects. The data presented provide insight into the potential role these molecules may play in the etiopathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580443     DOI: 10.1097/ICO.0b013e318254c028

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  Prolactin-Induced Protein is a novel biomarker for Keratoconus.

Authors:  Rabab Sharif; Sashia Bak-Nielsen; Henrik Sejersen; Kai Ding; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2018-10-26       Impact factor: 3.770

2.  Corneal Oxidative Damage in Keratoconus Cells due to Decreased Oxidant Elimination from Modified Expression Levels of SOD Enzymes, PRDX6, SCARA3, CPSF3, and FOXM1.

Authors:  Shari R Atilano; Daniel H Lee; Paula S Fukuhara; Marilyn Chwa; Anthony B Nesburn; Nitin Udar; M Cristina Kenney
Journal:  J Ophthalmic Vis Res       Date:  2019 Jan-Mar

Review 3.  Nutritional and Metabolic Imbalance in Keratoconus.

Authors:  Romina Mayra Lasagni Vitar; Filippo Bonelli; Paolo Rama; Giulio Ferrari
Journal:  Nutrients       Date:  2022-02-21       Impact factor: 5.717

4.  Biochemical and molecular alterations and potential clinical applications of biomarkers in keratoconus.

Authors:  Vaitheeswaran G Lalgudi; Rohit Shetty; Kanwal K Nischal; Setareh Ziai; Mona Koaik; Swaminathan Sethu
Journal:  Saudi J Ophthalmol       Date:  2022-04-09

5.  Higher Expression of Toll-Like Receptors 2 and 4 in Blood Cells of Keratoconus Patiens.

Authors:  Tomás Sobrino; Uxía Regueiro; Mercedes Malfeito; Alba Vieites-Prado; María Pérez-Mato; Francisco Campos; Isabel Lema
Journal:  Sci Rep       Date:  2017-10-11       Impact factor: 4.379

6.  Serum 25-Hydroxyvitamin D, Selenium, Zinc and Copper in Patients with Keratoconus.

Authors:  Siamak Zarei-Ghanavati; Bahareh Yahaghi; Samira Hassanzadeh; Majid Ghayour Mobarhan; Hamid Reza Hakimi; Pardis Eghbali
Journal:  J Curr Ophthalmol       Date:  2020-03-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.